<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anesthesia for living kidney donors
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anesthesia for living kidney donors
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anesthesia for living kidney donors
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Hendrikus J M Lemmens, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael F O'Connor, MD, FCCM
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel C Brennan, MD, FACP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Albert Q Lam, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3923661647">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Living kidney donors are in good health, with normal kidney function, and without chronic illness or clinically significant hypertension. This topic will review anesthetic management of the living donor during nephrectomy, with emphasis on the primary considerations of safety and comfort.
        </p>
        <p>
         The medical evaluation of a prospective living kidney donor, the risks of donor nephrectomy, and the techniques of living-donor nephrectomy are reviewed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7315.html" rel="external">
          "Kidney transplantation in adults: Evaluation of the living kidney donor candidate"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/103489.html" rel="external">
          "Kidney transplantation in adults: Risk of living kidney donation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H478347478">
         <span class="h1">
          OVERVIEW OF LIVING DONOR KIDNEY TRANSPLANTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Kidneys from living donors have better graft and patient survival rates for the recipient than kidneys from deceased donors. This is because living donors are physiologically and hemodynamically normal; hence, the graft is not exposed to ischemic alterations associated with brain death or cardiac death in deceased donors. Also, transplantation can be scheduled electively, with both donor and recipient surgeries coordinated at the same facility. This minimizes cold ischemia time for the donated kidney.
        </p>
        <p>
         In ideal circumstances, kidney transplantation from a living donor is preemptive, so that the recipient with end-stage kidney disease (ESKD) avoids the complications of dialysis altogether. Details are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7334.html" rel="external">
          "Kidney transplantation in adults: Timing of transplantation and issues related to dialysis", section on 'Preemptive transplantation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7349.html" rel="external">
          "Kidney transplantation in diabetic kidney disease", section on 'Preemptive transplantation and living-donor versus deceased-donor kidneys'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7309.html" rel="external">
          "Kidney transplantation in adults: Evaluation of the potential kidney transplant recipient", section on 'Timing of referral'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H478347511">
         <span class="h1">
          PREANESTHESIA CONSULTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Potential donors are extensively evaluated prior to being accepted as donors. As a result, thorough medical and surgical evaluations are always available at the time of the preanesthesia consultation. (See
         <a class="medical medical_review" href="/z/d/html/7315.html" rel="external">
          "Kidney transplantation in adults: Evaluation of the living kidney donor candidate", section on 'Donor evaluation'
         </a>
         .)
        </p>
        <p>
         Healthy donors are exposed to some, albeit limited, medical and surgical risks, as well as some degree of postoperative pain. (See
         <a class="medical medical_review" href="/z/d/html/103489.html" rel="external">
          "Kidney transplantation in adults: Risk of living kidney donation"
         </a>
         and
         <a class="local">
          'Pain management'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H839042598">
         <span class="h1">
          SURGICAL DETAILS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Donor nephrectomy from a living donor may be performed using an open or laparoscopic-assisted technique. The open technique utilizes retroperitoneal exposure of the kidney, whereas the laparoscopic technique employs an intraperitoneal approach.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laparoscopic nephrectomy
         </strong>
         –
         <strong>
         </strong>
         A majority of live kidney donations in the United States are performed via laparoscopy rather than via open nephrectomy with a large incision. Advantages include significantly less pain and a shorter recovery period and hospital stay without increased complication rates [
         <a href="#rid1">
          1,2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Laparoscopic-assisted technique'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Open nephrectomy
         </strong>
         –
         <strong>
         </strong>
         A large subcostal (flank) incision is made, typically from the lateral border of the left rectus at the level of the umbilicus to a point underneath the 12
         <sup>
          th
         </sup>
         rib. Open nephrectomy is more painful and is associated with a longer recovery period and hospital stay compared with laparoscopic nephrectomy [
         <a href="#rid1">
          1,2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Open technique'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Minimally invasive nephrectomy
         </strong>
         –
         <strong>
         </strong>
         A variation of the open nephrectomy technique is the minimally invasive nephrectomy, with a smaller, more anterior subcostal incision that leaves the 12
         <sup>
          th
         </sup>
         rib intact. This approach has also been associated with less postoperative pain and shorter hospital stay than the traditional open procedure [
         <a href="#rid3">
          3
         </a>
         ] but more pain and longer hospital stay than the laparoscopic technique [
         <a href="#rid2">
          2,4
         </a>
         ]. There have been several reports of robot-assisted laparoscopic donor nephrectomy, although it is not clear whether there are any additional advantages for this technique (eg, less blood loss) compared with conventional laparoscopic nephrectomy. (See
         <a class="medical medical_review" href="/z/d/html/7328.html" rel="external">
          "Kidney transplantation in adults: Benefits and complications of minimally invasive live-donor nephrectomy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Intraoperative surgical considerations for both open and laparoscopic-assisted donor nephrectomy include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibiotic prophylaxis
         </strong>
         –
         <strong>
         </strong>
         Antibiotic prophylaxis is administered within the 60 minutes prior to surgical incision [
         <a href="#rid5">
          5
         </a>
         ]. This is discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Antibiotic administration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Positioning
         </strong>
         –
         <strong>
         </strong>
         Positioning is similar with either laparoscopic or open techniques. The left kidney is usually harvested due to its longer renal vein. Thus, with either a laparoscopy-assisted technique or planned open approach, the patient is placed left-side up in lateral decubitus position, with elevation of the kidney bar of the operating table. Some surgeons also flex the table. A chest roll is usually placed caudal to the axilla to prevent compression injuries of axillary structures. (See
         <a class="medical medical_review" href="/z/d/html/94593.html" rel="external">
          "Patient positioning for surgery and anesthesia in adults", section on 'Nerve injuries associated with the lateral decubitus position'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anticoagulation and reversal of anticoagulation
         </strong>
         – Most surgeons request administration of intravenous heparin 3000 to 5000 units to achieve anticoagulation immediately before clamping the renal vessels [
         <a href="#rid6">
          6,7
         </a>
         ]. Then the renal artery and vein are separately clamped and divided, and the kidney is removed. Subsequent reversal of anticoagulation with protamine may be requested by the surgeon to achieve hemostasis. (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Open technique'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H478347692">
         <span class="h1">
          ANESTHETIC MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H3023731865">
         <span class="h2">
          General considerations
         </span>
        </p>
        <p class="headingAnchor" id="H33975352">
         <span class="h3">
          Vascular access
         </span>
         <span class="headingEndMark">
          —
         </span>
         We insert two large-bore intravascular catheters because significant bleeding is a possibility, although rare [
         <a href="#rid8">
          8
         </a>
         ]. Invasive monitoring (eg, insertion of a central venous catheter or arterial catheter) is not indicated.
        </p>
        <p class="headingAnchor" id="H33974767">
         <span class="h3">
          Induction and maintenance of general anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         General anesthesia is employed for either laparoscopic or open nephrectomy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Induction
         </strong>
         –
         <strong>
         </strong>
         For most kidney donors, we suggest intravenous (IV)
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         for induction of general anesthesia because of its antiemetic properties (see
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents", section on 'Propofol'
         </a>
         ). We administer a neuromuscular blocking agent (NMBA) to achieve tracheal intubation. We typically add a short-acting opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         or
         <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">
          sufentanil
         </a>
         ) to attenuate the stress response to laryngoscopy and endotracheal intubation. Details regarding these induction techniques are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/94135.html" rel="external">
          "Induction of general anesthesia: Overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintenance
         </strong>
         –
         <strong>
         </strong>
         Maintenance of general anesthesia may be achieved with either a potent volatile inhalation agent, total intravenous anesthesia (TIVA), or a combination of these techniques. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         An NMBA is administered to avoid high intra-abdominal pressure, which is especially important during abdominal distention with carbon dioxide (CO
         <sub>
          2
         </sub>
         ) during laparoscopic nephrectomy. (See
         <a class="local">
          'Considerations for laparoscopic nephrectomy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          Sevoflurane
         </a>
         has theoretical kidney toxicity due to an inorganic fluoride ion metabolite and formation of a substance known as compound A. However, sevoflurane has not been associated with clinically significant kidney injury, and has been used safely in patients with stable chronic kidney disease and in patients on dialysis. We use fresh gas flows &gt;2 L/minute to avoid formation of compound A when sevoflurane is administered. (See
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Sevoflurane'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We avoid
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         (N
         <sub>
          2
         </sub>
         O) because it may cause bowel distention that interferes with the surgical view and procedural tasks [
         <a href="#rid9">
          9
         </a>
         ]. Also, N
         <sub>
          2
         </sub>
         O is associated with a modestly higher incidence of postoperative nausea and vomiting (PONV) compared with other inhalation anesthetic agents. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Nitrous oxide gas'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Disadvantages and adverse effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         It is not necessary to avoid IV anesthetic agents excreted by the kidney since kidney function is generally good (ie, estimated glomerular filtration rate [GFR] &gt;60 mL/minute per 1.73 m
         <sup>
          2
         </sup>
         ), even after nephrectomy. However, we avoid all nephrotoxic agents to preserve function in the remaining kidney.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1640772551">
         <span class="h3">
          Mechanical ventilation
         </span>
         <span class="headingEndMark">
          —
         </span>
         We employ standard lung protective settings for mechanical ventilation (eg, pressure-controlled ventilation with 6 to 8 mL/kg, based on ideal body weight, positive end-expiratory pressure [PEEP] of 5 to 10 cmH
         <sub>
          2
         </sub>
         O), as well as recruitment maneuvers [
         <a href="#rid10">
          10
         </a>
         ]. These issues are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'
         </a>
         .)
        </p>
        <p>
         Modifications in ventilator settings become necessary during portions of a laparoscopic nephrectomy procedure. (See
         <a class="local">
          'Modifications of mechanical ventilation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H33975874">
         <span class="h3">
          Maintenance of kidney perfusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major risk to the kidney that is being transplanted is ischemia, which can be associated with delayed graft function in the recipient (see
         <a class="medical medical_review" href="/z/d/html/7302.html" rel="external">
          "Kidney transplantation in adults: Risk factors for graft failure", section on 'Tissue injury'
         </a>
         ). Thus, it is important to maintain kidney perfusion with a goal for urine output &gt;1 mL/kg per hour. Specific measures include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintaining intravascular volume
         </strong>
         – Intravascular volume is expanded with IV fluid (typically balanced crystalloid solutions) throughout the procedure to maintain optimal kidney perfusion and continuous urine output. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Crystalloid solutions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Volume requirements may be greater in patients undergoing laparoscopic nephrectomy compared with open nephrectomy to counteract the effect of the intraperitoneal gas on renal blood flow. (See
         <a class="local">
          'Strategies to maintain hemodynamic stability'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintaining adequate mean arterial pressure (MAP)
         </strong>
         –
         <strong>
         </strong>
         Maintenance of MAP is extremely important. This is primarily accomplished by maintaining optimal intravascular volume, which maintains cardiac filling and output.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Vasopressors, particularly pure alpha agonists, are avoided if possible as these drugs may interfere with kidney perfusion. If necessary, an inotrope/vasopressor agent such as bolus doses of
         <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">
          ephedrine
         </a>
         5 to 25 mg is administered to treat episodes of hypotension by increasing cardiac output and blood pressure. Very rarely, a continuous infusion of
         <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">
          norepinephrine
         </a>
         (at 1 to 30 mcg/min; 0.01 to 0.3 mcg/kg/min) may be necessary to treat significant hypotension refractory to volume administration and boluses of less potent agents. Norepinephrine acts on both alpha
         <sub>
          1
         </sub>
         and beta
         <sub>
          1
         </sub>
         adrenergic receptors to produce potent vasoconstriction and a modest increase in cardiac output [
         <a href="#rid11">
          11,12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Avoiding high intraabdominal pressure
         </strong>
         –
         <strong>
         </strong>
         This is accomplished by administering an NMBA to provide muscle relaxation in both open or laparoscopic nephrectomy procedures. Also, use of low CO
         <sub>
          2
         </sub>
         insufflation pressures is ensured
         <strong>
         </strong>
         during laparoscopy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintaining urine output
         </strong>
         – Most centers prophylactically administer 12.5 to 25 g of
         <a class="drug drug_general" data-topicid="9587" href="/z/d/drug information/9587.html" rel="external">
          mannitol
         </a>
         IV during the dissection phase as well as
         <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">
          furosemide
         </a>
         20 mg IV 15 to 20 minutes before the anticipated cross clamping of the renal artery to maintain urine output. (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Living-donor kidneys'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Open technique'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H175005881">
         <span class="h2">
          Considerations for laparoscopic nephrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         General anesthesia with endotracheal intubation is necessary for laparoscopic nephrectomy due to (see
         <a class="medical medical_review" href="/z/d/html/100120.html" rel="external">
          "Anesthesia for laparoscopic and abdominal robotic surgery in adults"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The need to avoid patient discomfort associated with pneumoperitoneum.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The need for controlled ventilation to reduce the increase in partial pressure of carbon dioxide (PaCO
         <sub>
          2
         </sub>
         ) caused by CO
         <sub>
          2
         </sub>
         insufflation and to avoid ventilatory compromise from the pneumoperitoneum itself.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The need for muscle relaxation to reduce the intra-abdominal pressure needed for the desired degree of abdominal distention.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33974240">
         <span class="h3">
          Modifications of mechanical ventilation
         </span>
         <span class="headingEndMark">
          —
         </span>
         During laparoscopic nephrectomy, changes in pulmonary function (eg, reduction in lung volume, increase in peak inspiratory pressure, and decrease in pulmonary compliance) usually require modifications in mechanical ventilation settings [
         <a href="#rid13">
          13
         </a>
         ]. High intrathoracic pressures are avoided (see
         <a class="local">
          'Maintenance of kidney perfusion'
         </a>
         above). Furthermore, insufflation of CO
         <sub>
          2
         </sub>
         may result in hypercapnia. Thus, we increase minute ventilation as necessary by increasing the respiratory rate while maintaining a constant tidal volume. (See
         <a class="medical medical_review" href="/z/d/html/100120.html" rel="external">
          "Anesthesia for laparoscopic and abdominal robotic surgery in adults"
         </a>
         .)
        </p>
        <p>
         However, we tolerate mild hypercapnia (ie, an end-tidal CO
         <sub>
          2
         </sub>
         [ETCO
         <sub>
          2
         </sub>
         ] of 45 mmHg) that typically develops during laparoscopy with CO
         <sub>
          2
         </sub>
         insufflation. Mild hypercapnia may improve tissue oxygenation and perfusion due to vasodilation and increased cardiac output, and also may increase oxygen offloading due to a rightward shift of the oxyhemoglobin dissociation curve [
         <a href="#rid13">
          13-15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H33974856">
         <span class="h3">
          Strategies to maintain hemodynamic stability
         </span>
         <span class="headingEndMark">
          —
         </span>
         Strategies to maintain hemodynamic stability include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Expand intravascular volume
         </strong>
         – Hypovolemia due to bleeding is treated with intravascular volume expansion (see
         <a class="local">
          'Maintenance of kidney perfusion'
         </a>
         above). Volume requirements during laparoscopic nephrectomy total 2 to 4 L of a balanced crystalloid solution. More aggressive fluid resuscitation is not associated with improved outcomes in the donor or recipient but may prolong hospital stay of the donor [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         This is typically necessary to counteract adverse effects of the intraperitoneal gas on blood flow to the kidney due to increased intraperitoneal pressure during CO
         <sub>
          2
         </sub>
         gas insufflation. (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Laparoscopic-assisted technique'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ensure low insufflation pressures
         </strong>
         – The pneumoperitoneum pressure created with insufflation of CO
         <sub>
          2
         </sub>
         is kept &lt;15 mmHg to avoid decreased perfusion to the kidney. Limiting the pneumoperitoneum pressure to &lt;15 mmHg during insufflation of CO
         <sub>
          2
         </sub>
         minimizes alterations in cardiovascular function. (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Laparoscopic-assisted technique'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treat increased systemic vascular resistance (SVR)
         </strong>
         –
         <strong>
         </strong>
         Increased SVR (and consequently increased MAP) may occur due to CO
         <sub>
          2
         </sub>
         absorption with resultant increased sympathetic output, as well as the neuroendocrine response to compression of the arterial vasculature caused by increased intra-abdominal pressure during CO
         <sub>
          2
         </sub>
         insufflation [
         <a href="#rid13">
          13,17-19
         </a>
         ]. When depth of anesthesia is adequate, a MAP &gt;95 mmHg can be treated with short-acting antihypertensive agents such as
         <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">
          labetalol
         </a>
         .
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H40535280">
         <span class="h2">
          Considerations for open and minimally invasive nephrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         These procedures are more painful than a laparoscopic procedure. General anesthesia is often combined with an epidural or other regional techniques for postoperative analgesia. (See
         <a class="local">
          'After open nephrectomy or minimally invasive nephrectomy'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults", section on 'Regional anesthesia techniques'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H33974875">
         <span class="h1">
          POSTOPERATIVE CONSIDERATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H33975676">
         <span class="h2">
          Pain management
         </span>
        </p>
        <p class="headingAnchor" id="H33975488">
         <span class="h3">
          After laparoscopic nephrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mild or moderate pain after laparoscopic nephrectomy may result from the port insertion site, the abdominal incision, pelvic organ manipulation, diaphragmatic irritation, and/or ureteral colic [
         <a href="#rid20">
          20
         </a>
         ]. This pain is managed with supplemental intravenous (IV) opioids using patient-controlled analgesia (PCA) for one or two days, and subsequently with oral opioids and
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         . Although one to two doses of
         <a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">
          ketorolac
         </a>
         can be administered for pain control in young donors, we generally avoid this nonsteroid anti-inflammatory drug (NSAID) in older donors [
         <a href="#rid21">
          21-23
         </a>
         ]. Subfascial infiltration of
         <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">
          bupivacaine
         </a>
         (0.5%) may also be employed to minimize opioid dosing [
         <a href="#rid24">
          24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/134254.html" rel="external">
          "Use of opioids for postoperative pain control", section on 'Patient controlled analgesia'
         </a>
         .)
        </p>
        <p>
         Other interventions to further improve pain control are under investigation. An enhanced recovery protocol after laparoscopic nephrectomy has been studied, emphasizing preoperative carbohydrate loading and a multimodal pain management regimen that included a transversus abdominis plane (TAP) regional block [
         <a href="#rid25">
          25
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/122399.html" rel="external">
          "Transversus abdominis plane (TAP) blocks procedure guide"
         </a>
         ). One study reported decreased length of stay in the hospital (from two days to one day) and decreased overall opioid use compared with a historical control group. (See
         <a class="medical medical_review" href="/z/d/html/133187.html" rel="external">
          "Nonopioid pharmacotherapy for acute pain in adults", section on 'Gabapentinoids'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H33975595">
         <span class="h3">
          After open nephrectomy or minimally invasive nephrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pain may be moderate to severe after open or minimally invasive nephrectomy. The pain associated with a subcostal lateral incision may last for several days. This can result in pulmonary complications (eg, atelectasis and pneumonia) [
         <a href="#rid26">
          26
         </a>
         ]. In most patients, adequate control of postoperative pain is achieved with epidural analgesia or PCA with opioids. Alternatively, multimodal opioid-sparing techniques such as continuous thoracic paravertebral block (PVB), erector spinae block, or intercostal blocks may be employed.
        </p>
        <p>
         Details regarding these strategies are available in other topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/118479.html" rel="external">
          "Continuous epidural analgesia for postoperative pain: Technique and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/134254.html" rel="external">
          "Use of opioids for postoperative pain control", section on 'Patient controlled analgesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/126309.html" rel="external">
          "Thoracic paravertebral block procedure guide"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/100071.html" rel="external">
          "Thoracic nerve block techniques", section on 'Intercostal nerve block'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/138905.html" rel="external">
          "Erector spinae plane block procedure guide"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1263106931">
         <span class="h2">
          Complications
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gastrointestinal complications
         </strong>
         –
         <strong>
         </strong>
         Gastrointestinal complications such as postoperative nausea, vomiting, constipation, and ileus are more common after open nephrectomy compared with laparoscopic nephrectomy. Multimodal measures (eg,
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         4 to 8 mg administered after induction of anesthesia and
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         4 mg administered at the end of surgery) are employed to prevent and treat these side effects of anesthesia and open or laparoscopic surgery. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15155.html" rel="external">
          "Measures to prevent prolonged postoperative ileus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary complications
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laparoscopic nephrectomy
         </strong>
         –
         <strong>
         </strong>
         For patients undergoing laparoscopic nephrectomy, the intraoperative reductions in lung volume that occur during insufflation of carbon dioxide (CO
         <sub>
          2
         </sub>
         )
         <sub>
         </sub>
         are temporary and typically resolve quickly after desufflation.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Open nephrectomy
         </strong>
         –
         <strong>
         </strong>
         After open nephrectomy, pulmonary complications in the early postoperative period may occur due to moderate to severe pain, particularly with a subcostal lateral incision. Pain limits the patient’s efforts to breathe, cough, and move, potentially resulting in atelectasis and pneumonia [
         <a href="#rid26">
          26
         </a>
         ]. (See
         <a class="local">
          'After open nephrectomy or minimally invasive nephrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Although other cardiopulmonary complications after open nephrectomy are rare, pulmonary embolism has been reported in large series [
         <a href="#rid8">
          8,27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/88846.html" rel="external">
          "Complications of laparoscopic surgery"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bleeding
         </strong>
         –
         <strong>
         </strong>
         Significant bleeding is rare after either surgical technique, occurring in 0.1 to 0.45 percent of donors [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Venous thromboembolism
         </strong>
         – Venous thromboembolism (VTE) is not a common complication following laparoscopic nephrectomy. Prevention of VTE after donor nephrectomy is similar to that for other adult patients undergoing nonorthopedic surgery, as discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2186724212">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         –
         <strong>
         </strong>
         Living kidney donors are physiologically and hemodynamically intact; hence, the graft is not exposed to ischemic alterations associated with brain or cardiac death. Transplantation is scheduled electively, with both donor and recipient surgeries coordinated at the same facility, thus minimizing cold ischemia time for the donated kidney. (See
         <a class="local">
          'Overview of living donor kidney transplantation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preanesthesia consultation
         </strong>
         –
         <strong>
         </strong>
         Potential donors are extensively evaluated prior to being accepted as donors. Thorough medical and surgical evaluations are available for the preanesthesia consultation. (See
         <a class="medical medical_review" href="/z/d/html/7315.html" rel="external">
          "Kidney transplantation in adults: Evaluation of the living kidney donor candidate", section on 'Donor evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgical details
         </strong>
         – Living donor nephrectomy may be performed using an open, laparoscopic-assisted, or minimally invasive technique; open nephrectomy is more painful and associated with longer hospital stays. The left kidney is usually harvested; the patient is in lateral decubitus position with elevation of the operating table kidney bar. Anticoagulation is generally avoided; however, some surgeons administer heparin to achieve anticoagulation before clamping the renal vessels. (See
         <a class="local">
          'Surgical details'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Vascular access
         </strong>
         –
         <strong>
         </strong>
         We insert two large-bore intravascular catheters. (See
         <a class="local">
          'Vascular access'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          General anesthesia
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Induction
         </strong>
         –
         <strong>
         </strong>
         For most kidney donors, we suggest intravenous (IV)
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         for induction of general anesthesia (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ), because of its antiemetic properties. (See
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents", section on 'Propofol'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Maintenance
         </strong>
         –
         <strong>
         </strong>
         Either a potent volatile inhalation agent (eg,
         <a class="drug drug_general" data-topicid="8992" href="/z/d/drug information/8992.html" rel="external">
          isoflurane
         </a>
         or
         <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">
          desflurane
         </a>
         ), total intravenous anesthesia (TIVA), or a combination of these techniques may be used, and a neuromuscular blocking agent (NMBA) is administered. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         If
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         is administered, we use fresh gas flows &gt;2 L/minute. We avoid
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         (N
         <sub>
          2
         </sub>
         O) as it may cause bowel distention. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Nitrous oxide gas'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Disadvantages and adverse effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mechanical ventilation
         </strong>
         –
         <strong>
         </strong>
         We employ standard lung protective settings, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Maintenance of kidney perfusion
         </strong>
         – It is important to maintain kidney perfusion and urine output. Specific measures include maintaining intravascular volume with IV fluid to maintain continuous urine output, maintaining adequate mean arterial pressure, and avoiding high intrabdominal pressure. (See
         <a class="local">
          'Maintenance of kidney perfusion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Considerations for laparoscopic nephrectomy
         </strong>
         –
         <strong>
         </strong>
         General anesthesia is necessary to minimize patient discomfort, control ventilation, and induce muscle relaxation to reduce intra-abdominal pressure during carbon dioxide (CO
         <sub>
          2
         </sub>
         ) insufflation. Modifications to mechanical ventilation settings are usually necessary to address changes in pulmonary function during laparoscopic nephrectomy. Strategies to maintain hemodynamic stability include ensuring low CO
         <sub>
          2
         </sub>
         insufflation pressure (&lt;15 mmHg), expanding intravascular volume, and treating increased systemic vascular resistance. (See
         <a class="local">
          'Considerations for laparoscopic nephrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Considerations for open and minimally invasive nephrectomy
         </strong>
         –
         <strong>
         </strong>
         General anesthesia is often combined with an epidural (to provide postoperative analgesia).
         <strong>
         </strong>
         (See
         <a class="medical medical_review" href="/z/d/html/7316.html" rel="external">
          "Deceased- and living-donor kidney allograft recovery", section on 'Open technique'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postoperative pain control
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Open and minimal invasive nephrectomy
         </strong>
         – Potentially severe pain is managed with epidural analgesia and/or patient-controlled analgesia (PCA) with opioids. (See
         <a class="local">
          'After open nephrectomy or minimally invasive nephrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laparoscopic nephrectomy
         </strong>
         – Mild or moderate pain is managed with PCA in the early postoperative period and subsequently with oral opioids and
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         . (See
         <a class="local">
          'After laparoscopic nephrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Wilson CH, Sanni A, Rix DA, Soomro NA. Laparoscopic versus open nephrectomy for live kidney donors. Cochrane Database Syst Rev 2011; :CD006124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis GR, Brook NR, Waller JR, et al. A comparison of traditional open, minimal-incision donor nephrectomy and laparoscopic donor nephrectomy. Transpl Int 2004; 17:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang SL, Harkaway R, Badosa F, et al. Minimal incision living donor nephrectomy: improvement in patient outcome. Urology 2002; 59:673.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perry KT, Freedland SJ, Hu JC, et al. Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol 2003; 169:2018.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmed Z, Uwechue R, Chandak P, et al. Prophylaxis of Wound Infections-antibiotics in Renal Donation (POWAR): A UK Multicentre Double Blind Placebo Controlled Randomised Trial. Ann Surg 2020; 272:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng EY, Leeser DB, Kapur S, Del Pizzo J. Outcomes of laparoscopic donor nephrectomy without intraoperative systemic heparinization. J Urol 2010; 183:2282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramani AP, Gill IS, Steinberg AP, et al. Impact of intraoperative heparin on laparoscopic donor nephrectomy. J Urol 2005; 174:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL. Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant 2003; 3:830.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Galley R, Hammontree L, Urban D, et al. Anesthesia for laparoscopic donor nephrectomy: is nitrous oxide contraindicated? J Urol 2007; 178:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meininger D, Byhahn C, Mierdl S, et al. Positive end-expiratory pressure improves arterial oxygenation during prolonged pneumoperitoneum. Acta Anaesthesiol Scand 2005; 49:778.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Redfors B, Bragadottir G, Sellgren J, et al. Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 2011; 37:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albanèse J, Leone M, Garnier F, et al. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004; 126:534.
          </a>
         </li>
         <li class="breakAll">
          Girish P. Joshi and Anthony Cunningham. Anesthesia for Laparoscopic and Robotic Surgeries. In: Clinical Anesthesia, Paul G. Barash (Ed), Lippincott Williams Wilkins, Philadelphia 2013. Vol Seventh, p.1257-73.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hager H, Reddy D, Mandadi G, et al. Hypercapnia improves tissue oxygenation in morbidly obese surgical patients. Anesth Analg 2006; 103:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fleischmann E, Herbst F, Kugener A, et al. Mild hypercapnia increases subcutaneous and colonic oxygen tension in patients given 80% inspired oxygen during abdominal surgery. Anesthesiology 2006; 104:944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams AM, Kumar SS, Bhatti UF, et al. The impact of intraoperative fluid management during laparoscopic donor nephrectomy on donor and recipient outcomes. Clin Transplant 2019; 33:e13542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Malley C, Cunningham AJ. Physiologic changes during laparoscopy. Anesthesiol Clin North America 2001; 19:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gutt CN, Oniu T, Mehrabi A, et al. Circulatory and respiratory complications of carbon dioxide insufflation. Dig Surg 2004; 21:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sammour T, Mittal A, Loveday BP, et al. Systematic review of oxidative stress associated with pneumoperitoneum. Br J Surg 2009; 96:836.
          </a>
         </li>
         <li class="breakAll">
          Randolph H. Steadman and Christopher L. Wray. Anesthesia for Abdominal Organ Transplantation. In: Miller's Anesthesia, Eighth, Ronald D. Miller (Ed), Elsevier, Philadelphia 2015. p.2262-91.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campsen J, Call T, Allen CM, et al. Prospective, double-blind, randomized clinical trial comparing an ERAS pathway with ketorolac and pregabalin versus standard of care plus placebo during live donor nephrectomy for kidney transplant. Am J Transplant 2019; 19:1777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takahashi K, Patel AK, Nagai S, et al. Perioperative Ketorolac Use: A Potential Risk Factor for Renal Dysfunction After Live-Donor Nephrectomy. Ann Transplant 2017; 22:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabrizian P, Giacca M, Prigoff J, et al. Renal Safety of Intravenous Ketorolac Use After Donor Nephrectomy. Prog Transplant 2019; 29:283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashcraft EE, Baillie GM, Shafizadeh SF, et al. Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated recovery. Clin Transplant 2001; 15 Suppl 6:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waits SA, Hilliard P, Sheetz KH, et al. Building the case for enhanced recovery protocols in living kidney donors. Transplantation 2015; 99:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feltracco P, Ori C. Anesthetic management of living transplantation. Minerva Anestesiol 2010; 76:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet 1992; 340:807.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 99956 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22071829" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Laparoscopic versus open nephrectomy for live kidney donors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15517169" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : A comparison of traditional open, minimal-incision donor nephrectomy and laparoscopic donor nephrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11992838" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Minimal incision living donor nephrectomy: improvement in patient outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12771708" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31714309" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Prophylaxis of Wound Infections-antibiotics in Renal Donation (POWAR): A UK Multicentre Double Blind Placebo Controlled Randomised Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20400133" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Outcomes of laparoscopic donor nephrectomy without intraoperative systemic heparinization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15947643" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Impact of intraoperative heparin on laparoscopic donor nephrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12814474" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17512015" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Anesthesia for laparoscopic donor nephrectomy: is nitrous oxide contraindicated?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15954959" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Positive end-expiratory pressure improves arterial oxygenation during prolonged pneumoperitoneum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20949349" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15302741" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Renal effects of norepinephrine in septic and nonseptic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15302741" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Renal effects of norepinephrine in septic and nonseptic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16931680" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Hypercapnia improves tissue oxygenation in morbidly obese surgical patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16645445" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Mild hypercapnia increases subcutaneous and colonic oxygen tension in patients given 80% inspired oxygen during abdominal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30887610" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The impact of intraoperative fluid management during laparoscopic donor nephrectomy on donor and recipient outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11244911" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Physiologic changes during laparoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15010588" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Circulatory and respiratory complications of carbon dioxide insufflation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19591166" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Systematic review of oxidative stress associated with pneumoperitoneum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19591166" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Systematic review of oxidative stress associated with pneumoperitoneum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30589514" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Prospective, double-blind, randomized clinical trial comparing an ERAS pathway with ketorolac and pregabalin versus standard of care plus placebo during live donor nephrectomy for kidney transplant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28924138" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Perioperative Ketorolac Use: A Potential Risk Factor for Renal Dysfunction After Live-Donor Nephrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31185805" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Renal Safety of Intravenous Ketorolac Use After Donor Nephrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11903389" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated recovery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25313941" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Building the case for enhanced recovery protocols in living kidney donors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20613693" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Anesthetic management of living transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1357243" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : 20 years or more of follow-up of living kidney donors.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
